Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
JAMA Network Open|December 20, 2021
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical TrialQing-Nan Tang, Li-Ting Liu, Bin Qi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2021
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinomaJin-Jie Yan, Shan-Shan Guo, Da-Feng Lin, et al.Med (New York, N.Y.)|March 31, 2026
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysisJia-Rui He, Yu-Xin Li, Bao-Cong Liu, et al.Annals of Translational Medicine|May 14, 2021
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort studyQing-Nan Tang, Hui-Zhi Qiu, Xiao-Qing Sun, et al.Journal of Cancer|May 29, 2018
The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort studySai-Lan Liu, Lin-Quan Tang, Qiu-Yan Chen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNALi-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, et al.International Journal of Radiation Oncology, Biology, Physics|July 19, 2019
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012Xue-Song Sun, Sai-Lan Liu, Mei-Juan Luo, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2019
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on induction chemotherapy responseSai-Lan Liu, Xue-Song Sun, Jin-Jie Yan, et al.Cancer Research and Treatment|July 15, 2017
Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective StudyQiu-Yan Chen, Qing-Nan Tang, Lin-Quan Tang, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2023
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patientsYu-Jing Liang, Qiu-Yan Chen, Jing-Xiao Xu, et al.Pageof 7